Microalbuminuria Predicting CIAKI After CAG (MPCC)

Clinical Trial ID NCT02808845

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02808845

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.	Am J Kidney Dis	2002	81.62
2	Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention.	Circulation	2002	4.99
3	Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.	J Am Coll Cardiol	2006	2.33
4	Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms.	J Am Soc Nephrol	2006	2.01
5	Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.	Kidney Int	2007	1.67
6	Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease.	Am J Cardiol	2009	1.51
7	Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality.	Ann Intern Med	2009	1.34
8	Update on microalbuminuria as a biomarker in renal and cardiovascular disease.	Curr Opin Nephrol Hypertens	2006	1.15
9	Contrast-induced nephropathy.	Catheter Cardiovasc Interv	2008	0.95
10	Contrast-induced nephropathy: pathogenesis and prevention.	Pediatr Nephrol	2009	0.82
11	Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.	Ren Fail	2013	0.76